Award Winning Care

McLaren Health Care and the Barbara Ann Karmanos Cancer Institute have earned the following awards and recognitions:

Karmanos, WSU Researcher Receives NIH Award to Explore Socio-genomic Factors of Local Endometrial Cancer Survival Rates

The National Cancer Institute of the National Institutes of Health has awarded Anna Gottschlich, Ph.D., M.P.H., member of the Population Studies and Disparities Research Program at the Barbara Ann Karmanos Cancer Institute and assistant professor of Oncology in the Wayne State University School of Medicine, a five-year, $916,545 career development award to support her research on the epidemiology of cancer health disparities and early detection and interception strategies to improve cancer equity. The g...

August 2025

Karmanos Assistant Director of Clinical Outreach Accepted into Prestigious Executive Leadership in Academic Medicine Program

Latonya Riddle-Jones, M.D., MPH, assistant director of Clinical Outreach at the Barbara Ann Karmanos Cancer Institute and associate professor of Internal Medicine and Pediatrics at the Wayne State University School of Medicine, has been selected as a fellow in the 2026 Class of the Executive Leadership in Academic Medicine® (ELAM) program at Drexel University College of Medicine. ELAM is the nation’s premier leadership training program for women in academic medicine, dentistry, public health, and pharma...

August 2025

Karmanos Associate Center Director Chosen for HERS Leadership Institute

Hayley Thompson, Ph.D., associate center director of Community Outreach and Engagement, faculty supervisor of the Office of Community Outreach and Engagement at the Barbara Ann Karmanos Cancer Institute, and professor of Oncology at Wayne State University (WSU), was selected to participate in the HERS Leadership Institute’s program for academic leadership development with support from WSU leadership. The program focuses on values-driven, equity-minded leadership while encouraging practical learning...

August 2025

KSP, McLaren’s Specialty Pharmacy, Recognized as a Leader in Performance Measurement for Third Consecutive Year

The Utilization Review Accreditation Commission (URAC) has again awarded KSP , McLaren’s Specialty Pharmacy, as a 2024 Specialty Pharmacy Pioneer in URAC’s Leaders in Performance Measurement (LPM) recognition program. As a URAC-accredited organization, this distinction shows that KSP continues demonstrating a commitment to improving health care quality and well-being through performance measurement. As a specialty pharmacy, KSP provides needed medications for patients with complex diseases or whose care...

August 2025

Karmanos’ Healing Arts Program Receives Grant Supporting Programs for Family Caregivers

A $300,000 grant from Exhale – The Family Caregiver Initiative will allow the Barbara Ann Karmanos Cancer Institute to continue providing its Give Yourself a Break Today program, a healing arts program for family caregivers and cancer thrivers. This gift supports the program for three years in partnership with other community groups. In Michigan alone, there are over 1.7 million family caregivers. Cancer is an incredibly relentless disease that takes a toll on patients tremendously. Cancer does not just...

July 2025

Karmanos Leader Selected as a Crain’s Notable Leader in Finance

Regina Doxtader, vice president and chief financial officer at the Barbara Ann Karmanos Cancer Institute , has been named to Crain’s Detroit’s 2025 Notable Leaders in Finance . Doxtader joined Karmanos in 2022. With over 35 years of health care financial leadership experience, she provides direction and oversight of financial planning, budgeting, and capital evaluation, as well as strategic financial insights related to growth initiatives, cost efficiency opportunities and network developmen...

June 2025

Karmanos Leader Selected as a Crain’s Notable Leader in Philanthropy

Arnold D’Ambrosio , chief development officer at the Barbara Ann Karmanos Cancer Institute , has been named to Crain’s Detroit’s 2025 Notable Leaders in Philanthropy . D’Ambrosio joined Karmanos in 2023 and leads fundraising strategy and execution. He has been instrumental in securing support for the organization's continued success by fostering strong relationships with corporate and community leaders, charitable foundations, board members, and volunteers. Since joining Karmanos, D’Ambrosio has success...

June 2025

Karmanos, WSU Researcher Honored for Groundbreaking Research on Cancer Communication in Families

Cinzia Caparso, Ph.D., RN, an assistant professor in the Wayne State University College of Nursing and a member of the Population Studies and Disparities Research (PSDR) Program at the Barbara Ann Karmanos Cancer Institute , has been named one of 12 national honorees for the prestigious 2025 Matilda White Riley Behavioral and Social Science Honor by the National Institutes of Health’s Office of Behavioral and Social Sciences Research (OBSSR). This annual honor recognizes early-stage investigators ...

June 2025

Dr. Wei-Zen Wei Honored with Prestigious Wayne State University Distinguished Service Professorship

Wei-Zen Wei, Ph.D., founding co-Chair of the Immunology Focus Group, member of the Tumor Biology and Microenvironment Research Program , and renowned faculty member at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, has been honored with the appointment to the rank of Distinguished Service Professor. Dr. Wei, who is also the Herrick Endowed Chair of Cancer Research, is recognized for her extraordinary service outside her discipline and outside WSU that broug...

June 2025

Karmanos, WSU Researcher Wins Scholar-in-Training Award, Presents KRAS Study Abstract at AACR Annual Meeting

A Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) research scientist and assistant professor, Husain Yar Khan, Ph.D., presented an abstract on “Targeting XPO1 to Enhance Durability of Response of MRTX1133 in Pancreatic Ductal Adenocarcinoma” at this year’s American Association for Cancer Research (AACR) Annual Meeting in Chicago. The study investigates how to improve the durability of response to KRAS inhibitors by combining them with the XPO1 inhibitor. In addition, Dr. Khan was ...

April 2025

U CAN-CER VIVE Gives $450K+ to Karmanos Cancer Institute for Continued Research in Using Radiofrequency to Treat Cancer

The Barbara Ann Karmanos Cancer Institute has been awarded $459,010 for continued research in treating cancers with radiofrequency electromagnetic fields. Leaders from U CAN-CER VIVE Foundation, an organization that supports cancer research in Michigan, delivered the check to Karmanos researchers in March. U CAN-CER VIVE was co-founded by Ryan and Kelley LaFontaine. The funds will help open clinical trial studies in cancer treatment of breast, colorectal and pancreatic cancers, and continue studies in l...

April 2025

Karmanos’ Community Outreach and Engagement Office Honored as Hometown Health Hero by the Michigan Public Health Week Partnership

The Barbara Ann Karmanos Cancer Institute’s Office of Community Outreach and Engagement (COE) has been named a 2025 Hometown Health Hero by the Michigan Public Health Week Partnership. This award recognizes people and organizations in Michigan working to improve the health of their communities. Leading community outreach and engagement efforts for Karmanos, COE monitors the cancer burden in the Karmanos 46-county catchment area and engages the community and Karmanos scientists in strategies to reduce th...

April 2025

Karmanos Recommended Nationwide by Optum for Transplants

The Barbara Ann Karmanos Cancer Institute has been named one of 168 medical centers in the country to which Optum recommends its payers refer their clients for blood and bone marrow transplants. With more than 3,000 payers using Optum in the U.S., a trusted information and technology-enabled health services business that delivers integrated solutions for health systems, more than 62 million people benefit from its tools. The company’s Centers for Excellence networks recognize “clinically superior provid...

April 2025

Karmanos Cancer Institute Only Cancer Center in Michigan Named to Optum’s 2025 List of Recommended Centers for Oncology Care

The Barbara Ann Karmanos Cancer Institute has been named one of 37 cancer centers nationwide and the only cancer center in Michigan to which Optum recommends its payers refer their clients for oncology care. With more than 3,000 payers using Optum in the U.S., a trusted information and technology-enabled health services business that delivers integrated solutions for health systems, more than 62 million people benefit from its tools. The company’s Centers of Excellence networks recognize clinically supe...

March 2025

Dr. Lydia Choi Named 2025 Exceptional Woman in Medicine by Castle Connolly

Lydia Choi, M.D. , breast surgical oncologist and member of the Breast Cancer Multidisciplinary Team at the Barbara Ann Karmanos Cancer Institute, has been named among more than 8,200 physicians on the Castle Connolly 2025 Exceptional Women in Medicine , an honor she has received consecutively since 2019. The list includes the top 2% of female physicians across the country. The women on this list have demonstrated leadership, expertise and dedication to their fields. In addition, these physi...

March 2025

18 Karmanos Physicians on Castle Connolly 2025 Top Doctors List

Castle Connolly’s 2025 Top Doctors list has been announced, with 18 Barbara Ann Karmanos Cancer Institute physicians listed. There are about 1 million practicing physicians in the U.S. Castle Connolly’s list includes over 70,000 physicians, the top 7% of physicians across the country, all board-certified in 85 medical specialties. Selection for the Top Doctors list is based on peer nominations (over 39,000 nominations were submitted in 2024), professional achievements, and excellence in patient care. A ...

February 2025

Karmanos VP of Marketing Named to Michigan Chronicle’s Women of Excellence List

Michigan Chronicle has named 50 trailblazing women to its annual Women of Excellence List . This includes the Barbara Ann Karmanos Cancer Institute ’s vice president of Marketing and Business Development, Tamara Collins. In an article, the Michigan Chronicle stated Collins, “uses her platform to promote awareness and early detection, crucial steps in combating cancer within our communities.” She stepped into her VP role at Karmanos in 2023 and has delivered transformative brand strategy, strategic plann...

February 2025

Karmanos, WSU Lands on Top 10 List for NRG Oncology Trials

NRG Oncology has named the Barbara Ann Karmanos Cancer Institute and Wayne State University among the “Top 10 Accruing Lead Academic Participating Sites” for oncology trials. In January, the organization announced the leading sites at its annual Winter Meeting in Phoenix, Arizona. Being acknowledged on this list means that Karmanos enrolled a high number of participants in therapeutic clinical trials between Jan. 1 and December 31, 2024. The clinical trials are National Clinical Trial Network (NCTN) and...

February 2025

Karmanos Cancer Institute Receives 2025 Women’s Choice Awards® for Cancer Care, Mammogram Imaging, Minimally Invasive Surgery and Patient Experience

The Barbara Ann Karmanos Cancer Institute has been named one of America’s 2025 Best Hospitals for Cancer Care, Mammogram Imaging, Minimally Invasive Surgery, and Patient Experience by the Women’s Choice Award ® , America’s trusted referral source for the best in health care. This is the 12 th consecutive year Karmanos has been recognized by the Women’s Choice Award® since the inception of the national list. “It is an honor to be awarded the Women’s Choice Award. This recognition reflects the except...

January 2025

Dr. George Yoo Named in Becker’s 2025 Chief Medical Officers to Know for the Second Year in a Row

George Yoo, M.D., FACS , chief medical officer (CMO) at Karmanos Cancer Hospital, was again listed on Becker’s Hospital Review’s Chief Medical Officers to Know . The 2025 list includes over 180 CMOs nationwide who “play a pivotal role in advancing patient safety, maintaining high-quality standards, bridging the gap between leadership and medical staff, and managing risk.” The CMOs named are leaders who are continually driven for improvement, leading to multiple quality and safety accolades for the...

December 2024

Karmanos Faculty Honored at Annual WSU School of Medicine Faculty Awards and Promotion and Tenure Ceremony

The Office of Faculty Affairs and Professional Development at Wayne State University’s (WSU) School of Medicine held its 2024 School of Medicine Faculty Awards and Promotion and Tenure Ceremony on Sept. 26. This is an annual recognition of faculty who have made outstanding contributions to teaching, mentoring, research, and leadership. This year, several Barbara Ann Karmanos Cancer Institute faculty, researchers and medical staff at the Karmanos Cancer Center received these awards, highlighting their si...

October 2024

Nerissa T. Viola, Ph.D., Receives 2024 Kales Award in Oncology

Nerissa T. Viola, Ph.D., leader of the Molecular Imaging Research Program at the Barbara Ann Karmanos Cancer Institute and associate professor at Wayne State University (WSU) School of Medicine, has won the 2024 Drs. Anthony and Joyce Danielski Kales Endowment Faculty Award for Innovative Cancer Research. Dr. Viola received this award for her role as the principal investigator in a collaborative preclinical study that succeeded in finding a way to potentially suppress tumor growth for prostate...

October 2024

Hour Detroit’s 2024 Top Docs List Includes Over 50 Karmanos Physicians

Hour Detroit’s 2024 Top Docs List is out; over 50 physicians from the Barbara Ann Karmanos Cancer Institute are listed. Each year, Hour Detroit Magazine puts out an online peer-to-peer review survey conducted by Professional Research Services (PRS) to determine the top physicians in southeastern Michigan. Participating physicians in Livingston, Macomb, Oakland, Washtenaw, and Wayne Counties nominate the best doctors in each field. This year’s list also includes a feature with Elisabeth...

October 2024

Three McLaren Health Care, Karmanos Cancer Institute Top Executives Recognized in DBusiness Magazine’s ‘Detroit 500’ List

President and CEO of McLaren Health Care, Philip A. Incarnati, President and CEO of the Barbara Ann Karmanos Cancer Institute, Boris C. Pasche, M.D., Ph.D., FACP, and President of the Karmanos Cancer Hospital and Karmanos Cancer Network, Brian R. Gamble, have been included in this year’s “Detroit 500.” An annual feature from DBusiness Magazine, the “Detroit 500” compiles the 500 most influential business leaders in metro Detroit. Individuals are selected based on several factors, including the company o...

September 2024

Two Karmanos Leaders Named Health Care Heroes

The 2024 list of Crain’s Detroit Business Health Care Heroes contains two Karmanos Cancer Institute leaders: Boris C. Pasche, M.D., Ph.D., FACP, and Michael Dominello, D.O. Advancements in Care Hero Dr. Pasche, president and CEO of the Barbara Ann Karmanos Cancer Institute, was named an Advancements in Care Hero for his co-invention of the Therabionic P1 device. He and his co-inventor, Alexandre Barbault, started studying the use of low-level radiofrequency electromagnetic fields to treat cancer in the ...

June 2024

Dr. George Yoo Named in Becker’s 2024 Chief Medical Officers to Know

George Yoo, M.D., FACS , chief medical officer (CMO) at Karmanos Cancer Hospital, was listed on Becker’s Hospital Review’s 2024 Chief Medical Officers to Know . The list includes 180 CMOs who “champion patient safety, uphold rigorous quality standards, act as liaisons between leadership teams and medical staff, manage risk,” and more. The CMOs named are considered leaders who are continually driven for improvement, leading to multiple quality and safety accolades for their organizations. Dr. Yoo became ...

May 2024

Karmanos Cancer Institute receives 2024 Women’s Choice Awards® for cancer care and patient experience

The Barbara Ann Karmanos Cancer Institute has been named one of America’s 2024 Best Hospitals for Cancer Care and one of the country’s 100 Best Hospitals for Patient Experience by the Women’s Choice Award ® , America’s trusted referral source for the best in health care. This is the 11 th consecutive year Karmanos has been recognized by the Women’s Choice Award® since the inception of the national list. “A woman’s influence on where she chooses to receive health care is powerful, and we are once ag...

December 2023

Karmanos awarded bronze for Integrated Campaign of the Year

Modern Healthcare and Ad Age has recognized the Barbara Ann Karmanos Cancer Institute with the Bronze Award for Integrated Campaign of the Year for the latest installment of the “Inspire” campaign. The award was given as part of the 2023 Healthcare Marketing Impact Awards . Karmanos partnered with Fusion92, a marketing agency, for the latest era of the “Inspire” campaign to showcase a cancer patient’s perspective on everyday life and activities. The campaign took viewers on a journey and included digita...

November 2023

McLaren, Karmanos listed among best oncology programs in US

McLaren Health Care has been included on the 2023 list of “100 hospitals and health systems with great oncology programs” compiled by Becker’s Hospital Review. The health system has Michigan’s largest network of oncology centers, the Karmanos Cancer Network , anchored by the Barbara Ann Karmanos Cancer Institute in Detroit. The list includes the premier providers of cancer care from across the country, many of which are National Cancer Institute (NCI)-Designated Oncology Centers. The oncology programs p...

October 2023

WSU celebrates School of Medicine, Karmanos faculty for their significant contributions to further education

The Office of Faculty Affairs and Professional Development at Wayne State University’s (WSU) School of Medicine annually recognizes faculty who have made outstanding contributions in teaching, mentoring, research, and leadership. This year, several Barbara Ann Karmanos Cancer Institute faculty, researchers, and medical staff at the Karmanos Cancer Center received these awards, highlighting their significant contributions to education and more. Others received promotions and tenure at Wayne State. School...

October 2023

Hour Detroit’s 2023 Top Docs List includes over 30 Karmanos physicians

Hour Detroit’s 2023 Top Docs List is out; over 30 physicians from the Barbara Ann Karmanos Cancer Institute are listed. Each year, Hour Detroit Magazine puts out an online peer-to-peer review survey conducted by Professional Research Services (PRS) to determine the top physicians in southeastern Michigan. Participating physicians in Wayne, Oakland, Macomb, Washtenaw, and Livingston Counties nominate the best doctors in each field. This year’s list also includes a feature with George Yo...

October 2023

Patients rate Karmanos as a top-recommended hospital, with high ratings for physician communication, nurse communication, staff responsiveness, patient experience and drug communication

Karmanos Cancer Center is ranked among the top recommended hospitals in the state and country by patients. Becker’s Hospital Review compiled lists of high-scoring hospitals nationwide from data released by the Centers for Medicare & Medicaid Services (CMS). Among being a highly recommended hospital, Karmanos also scored high for physician-patient communication, nurse-patient communication, staff responsiveness, atient experience and drug communication. The data comes from the Hospital Consumer Asses...

August 2023

Top executives at McLaren Health Care, Karmanos Cancer Institute recognized on DBusiness Magazine’s “Detroit 500” list

President and CEO of McLaren Health Care, Philip A. Incarnati, and President of Karmanos Cancer Hospital and Network, Brian R. Gamble, have been included in this year’s “Detroit 500.” An annual feature from DBusiness Magazine, the “Detroit 500” compiles the 500 most influential business leaders in metro Detroit. Individuals are selected based on several factors, including the company or organization size, growth rate, geographical reach and extensive personal contacts. View the complete “Detroit 500” li...

August 2023

KSP, McLaren’s Specialty Pharmacy, earns full URAC re-accreditation

KSP , McLaren Health Care's Specialty Pharmacy, has earned full re-accreditation for specialty pharmacy from URAC through August 1, 2026. By achieving this status, KSP has demonstrated its commitment to quality care, enhanced process, patient safety and improved outcomes. With this designation, KSP will continue providing specialty agents for various diseases. The medications and therapeutic follow-up offered by KSP are for patients with complex diseases or whose care requires high-cost treatments. Phys...

August 2023

3 McLaren hospitals recognized for physician-patient communication

Three McLaren Health Care system hospitals were recognized by Becker’s Hospital Review , a leading health care industry news outlet, for their physicians’ proficiency in effectively communicating with their patients . Compiled from publicly reported data measured by the Consumer Assessment of Healthcare Providers and Systems (HCAHPS) part of the Centers for Medicare and Medicaid Services (CMS), three McLaren Health Care hospitals earned five stars in physician communication, the highest achievable ratin...

July 2023

Two Karmanos behavioral health specialists named Notable Leaders by Crain’s Detroit Business

The 2023 list of Crain’s Notable Leaders in Behavioral Health contains two members of Karmanos’ Supportive Oncology Multidisciplinary Team (MDT): Felicity W.K. Harper, Ph.D., and Mary Morreale, M.D. The publication announced the list on Monday, May 22. Dr. Harper is a clinical psychologist, professor of oncology at Wayne State University (WSU) School of Medicine, and associate center director of Population Sciences at Karmanos. She has dedicated her leadership, research and clinical practice to improvin...

May 2023

KSP, McLaren’s Specialty Pharmacy, recognized as a Leader in Performance Measurement

The Utilization Review Accreditation Commission (URAC) has awarded KSP , McLaren’s Specialty Pharmacy, as a 2022 Pioneer in URAC’s Leaders in Performance Measurement (LPM) in their recognition program. This distinction shows that KSP has demonstrated a commitment to improving healthcare quality through performance measurement. As a specialty pharmacy, KSP provides needed medications and therapeutics at an affordable cost for patients with complex diseases or whose care requires high-cost treatments. Bei...

May 2023

Karmanos Cancer Institute’s Farmington Hills clinic designated an ACR Breast Imaging Center of Excellence

The Barbara Ann Karmanos Cancer Institute’s Lawrence and Idell Weisberg Cancer Center in Farmington Hills has been designated a Breast Imaging Center of Excellence by the American College of Radiology (ACR). By awarding facilities the status of a Breast Imaging Center of Excellence, the ACR recognizes breast imaging centers that have earned accreditation in mammography, stereotactic breast biopsy and breast ultrasound (including ultrasound-guided breast biopsy). Certified physicians and medical physicis...

December 2022

Karmanos Cancer Institute Receives the Women’s Choice Award® as one of America’s Best Hospitals for Cancer Care for 10th consecutive year

For the 10 th consecutive year, the Barbara Ann Karmanos Cancer Institute has been named one of America’s Best Hospitals for Cancer Care by the Women’s Choice Award ® , America’s trusted referral source for the best in health care. The award signifies that Karmanos is in the top 10 percent of 4,729 U.S. hospitals offering cancer care services. Karmanos has received this honor since the inception of the award in 2014. “This award speaks to our excellence in the care of cancer patients. We are proud...

December 2022

Karmanos receives renewal of membership in prestigious Prostate Cancer Clinical Trials Consortium

Elisabeth Heath, M.D., FACP, leader of the Genitourinary Oncology Multidisciplinary Team (MDT) and member of the Phase 1 Clinical Trials MDT at the Barbara Ann Karmanos Cancer Institute, has received grant renewal from the U.S. Department of Defense to continue membership in the prestigious Prostate Cancer Clinical Trials Consortium (PCCTC) program. The Prostate Cancer Clinical Consortium Award is a peer-reviewed, competitive grant. Peers include scientific researchers at universities and cancer centers...

October 2022

Karmanos Cancer Center receives overall 5-star rating on Medicare’s Care Compare website

Karmanos Cancer Center in Detroit now has a five-star overall rating, the highest rating possible, from the Centers of Medicare & Medicaid Services. The overall quality star rating compares the hospital’s performance to others across the country. The rating system includes five categories of quality: mortality, safety of care, readmission, patient experience and timely and effective care. Medicare provides the star-rating of each hospital on its Care Compare website, a user-friendly interface where ...

August 2022

Karmanos Cancer Institute and Network ranked as the preferred cancer provider in Michigan

The Karmanos Cancer Institute , the world renowned cancer center based in Detroit, for the first time since joining McLaren Health Care in 2014 has become the preferred cancer treatment provider in Michigan. A subsidiary of McLaren, the three-state, 14-hospital health system, the Karmanos Cancer Network of treatment facilities stretches across the state, from Petoskey to Detroit, and recently expanded into Ohio. In a poll conducted by NRC Health, 11.4 percent of statewide respondents named Karmanos and ...

July 2022

Wayne State University and Karmanos Cancer Institute express gratitude for $100 million from state for new medical education-research site

The Wayne State University School of Medicine and the Barbara Ann Karmanos Cancer Institute plan to construct a new building complex consisting of two towers that will further their unique academic and research-based partnership. The estimated $450 million capital project is becoming more of a reality with an appropriation of $100 million from the State of Michigan. WSU and Karmanos plan to house collaborative medical education, research and laboratories, health science and community health clinics in t...

July 2022

Karmanos and FocuSSTEM NextGen win three prestigious TV and video awards, teaching students STEM through VR and XR experiences

Karmanos Cancer Institute and FocuSSTEM NextGen have found a new way to remotely engage students during the pandemic, which has earned both organizations three Telly Awards. The awards are in the Immersive & Mixed Reality category. The Remote STEM Camp in Virtual Reality (VR) won a silver Telly Award in the general subcategory for education and training. The Live Summit in Extended Reality (XR) was awarded a silver Telly in the general subcategory for virtual events and experiences, as well as a bro...

July 2022

Karmanos granted Ralph C. Wilson, Jr. Legacy Funds to continue support for cancer caregivers

Barbara Ann Karmanos Cancer Institute received a $12,500 grant to support the Cancer Caregiver Community Program. The Community Foundation for Southeast Michigan and Ralph C. Wilson, Jr. Foundation announced the award through the Ralph C. Wilson, Jr. Legacy Funds in May. Karmanos will utilize the award to continue and enhance programming for cancer caregivers in metro Detroit. “We support cancer caregivers throughout our community, whether they are friends of one of our cancer patients or family,” said ...

June 2022

The American Cancer Society awards transportation grant to Karmanos Cancer Institute to facilitate access to cancer care

The American Cancer Society (ACS) recently awarded Barbara Ann Karmanos Cancer Institute $15,000 in transportation grant funding to help alleviate the financial burden of transportation for cancer patients. The transportation grant will assist cancer patients in Detroit and throughout the Karmanos Cancer Network, which reaches patients in 46-counties throughout Michigan and Lucas County in Ohio. With this grant, Karmanos will be able to assist at least 200 cancer patients. For cancer patients, lack of t...

May 2022

Barbara Ann Karmanos Cancer Institute & Network named recipient of the American Cancer Society lodging grant for cancer patients receiving treatment

The Barbara Ann Karmanos Cancer Institute was recently awarded a $50,000 lodging grant by the American Cancer Society to help eliminate the financial barriers of cancer treatment. These funds will be used to address the lodging needs of cancer patients receiving treatment in Detroit and throughout the Karmanos Cancer Network, which reaches patients in 46-counties throughout Michigan. An estimated 62,150 Michigan residents will learn they have cancer this year. The cost of lodging near their treatment ce...

January 2022

Karmanos Cancer Institute receives the 2022 Women’s Choice Award® as one of America’s Best Hospitals for Cancer Care and one of America’s Best Mammogram Imaging Centers

The Barbara Ann Karmanos Cancer Institute has been named one of America’s Best Hospitals for Cancer Care and by the Women’s Choice Award® , America’s trusted referral source for the best in health care. These awards signify that Karmanos Cancer Institute is in the top two percent of 4,542 U.S. hospitals offering cancer care services. A hospital must be designated by the American College of Surgeons’ Commission on Cancer Classification (ACS CoC) as one of four specific types of cancer programs to be cons...

December 2021

Asfar Azmi, Ph.D. receives 2021 Kales Award for breakthrough in pancreatic ductal adenocarcinoma treatment

Asfar Azmi, Ph.D., associate professor, Department of Oncology at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, has been selected as the winner of the 2021 Anthony and Joyce Danielski Kales Endowed Faculty Award for Innovative Cancer Researcher for his research on Selinexor with Gemcitabine and Nab-Paclitaxel for the treatment of pancreatic ductal adenocarcinoma. Dr. Azmi’s research, “Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine...

November 2021

Radhika Gogoi, M.D., receives Geri Fournier Ovarian Cancer Research Grant

Karmanos is pleased to congratulate Radhika Gogoi, M.D., Ph.D. , member of the Gynecologic Oncology Multidisciplinary Team at Karmanos for securing a Geri Fournier Ovarian Cancer Research Grant in the amount of $50,000. The annual award is given by The Michigan Ovarian Cancer Alliance to recognize and provide funding for the critical research happening in the state. Dr. Gogoi received the grant award for a research project that aims to identify differences between BRCA1 and BRCA2 proteins that may lead ...

October 2021